Download the application here or click the link on the right of this page.
The Advocacy Navigator is an AVAC initiative combining training and mentorship to young and emerging advocates in the field of HIV prevention advocacy. Mentors will serve as advisors to the Navigators, supporting them as they go through their coursework and while they design and implement their Community Advocacy Project. More information at www.avac.org/navigator.
Download the application here or click the link to the right of this page. Please note, you will need to download and fill the application on a laptop or desktop computer. It is not possible to use a mobile phone to fill out the application.
The Advocacy Navigator program is open to any individual interested in HIV prevention advocacy currently residing in Southern or Eastern Africa. This is a six month program with a three to four hour weekly time commitment. AVAC will provide online coursework in HIV prevention and advocacy and match participants with a mentor. Participants will receive a small project grant. More information at www.avac.org/navigator.
The Advocacy Navigator program is open to any AVAC Alumni interested in serving as a mentor to emerging HIV prevention advocates currently residing in Southern or Eastern Africa. This is a six month program in HIV prevention advocacy. The mentor time commitment should be approximately one to two hours per week with the Navigator program participant. A modest communication and mentorship stipend is available. More information at www.avac.org/navigator.
Avac Event
AVAC and REACH for the Cure hosted a webinar to discuss how the environment may impact HIV cure strategies. During this webinar, both organizations explored how clades, co-infections, early treatment, and other factors can help inform existing approaches to HIV cure research. Dr. Adam Ward of Weill Cornell Medicine shared the latest data followed by an informal conversation.
Avac Event
The new director of National Institute of Allergy and Infectious Diseases (NIAID), Dr. Jeanne Marrazzo joined AVAC Executive Director in conversation.
Avac Event
Thursday January 11, 8:00AM/4:00PM EAT
This webinar provided an overview of cervical cancer including what cervical cancer is, who is impacted, and prevention and treatment options.
Speakers included: Helen Kelly, Shona Dala, and Maribel Almonte Pacheco, WHO and Michelle Chevalier, US Department of State—Bureau of Global Health Security & Diplomacy/PEPFAR
Recording / Helen Kelly Slides
Thursday January 18, 8:00AM/4:00PM EAT
During this webinar, we heard from advocates on how they have used their voice to bring more attention to cervical cancer and its impact on communities.
Speakers include: Tamika Felder, Cervivor and Karen Nakawala, Teal Sisters Foundation Zambia
Recording / Tamika Felder Slides / Karen Nakawala Slides
Thursday January 25, 8:00AM/4:00PM EAT
During this webinar, speakers discussed options for screening and treating cervical cancer along with ongoing research.
Speakers include: Fred Wyand, American Sexual Health Association/National Cervical Cancer Coalition and Bothwell Guzha, University of Zimbabwe
Recording / Fred Wyand Slides / Bothwell Guzha Slides
Thursday February 1, 8:00AM/4:00PM EAT
This webinar explored how cervical cancer impacts key populations and those vulnerable to HIV infections.
Speakers include: Samiya Mahmoud, Association for the Prevention of Septic Abortion, Bangladesh (BAPSA) and Shona Dalal, Helen Kelly, WHO
For over a decade, the AVAC Advocacy Fellows Program has played a role in shaping the landscape of HIV prevention by strengthening leadership skills and building a growing and evolving network of fierce and unstoppable advocates. Last year, AVAC released A Legacy of Impact: The power and reach of AVAC’s Advocacy Fellows to tell the story of the Fellows program and to share testimonies of impact from research to policy, and beyond.
Today, on Martin Luther King Jr. Day, a day dedicated to the importance of advocacy to influence change, AVAC honors its nearly 100 Fellow alumni and applauds our most recent class which closed out their fellowship in December.
Read on for testimonies from the AVAC 2022/2023 Fellows and explore their work in their individual pages.
Learn about Ruth’s work around the approval and rollout of the dual prevention pill (DPP) in Uganda here.
Learn about Onward’s work with engaging religious institutions on adolescent sexual and reproductive health in Zimbabwe here.
Learn about Prince’s work ensuring access to injectable CAB for PrEP for trans people in Malawi here.
Learn about Catherine’s work in the rollout and implementation of the dapivirine vaginal ring for adolescents and young women (AGYW) in Tanzania here.
Learn about Natasha’s advocacy for the approval of the dapivirine vaginal ring and injectable CAB for PrEP in Zambia here.
Learn about Peter’s work with differentiated service delivery of PrEP and expediting new PrEP tools in Lesotho here.
Learn about Elizabeth’s work advocating for sex workers and people who use drugs (PUD) here.
Learn about Liyema’s work on advocating and implementing the decriminalization of sex work in South Africa here.
Get to know the full AVAC Fellows community by exploring the full alumni database and stay tuned to meet the 2024/2025 class to be announced in April!
In 2024 we look forward to continuing to provide advocates with tools to support our collective work to ensure access to PrEP in all its forms to all who can benefit from it.
PrEPWatch.org has grown significantly in the past year, reaching a growing number of implementers, policy makers and advocates with continually updated tools and information that are instrumental to delivering the growing range of HIV prevention options. Throughout 2023, visitors from every country in the world have used PrEPWatch.org, a one-stop online clearinghouse of data, guidelines, tracking tools and other resources to help the global community speed the delivery of every proven method of PrEP to everyone who needs it. Check out what’s new and updated on PrEPWatch.org!
Modelling the Scale-Up of Injectable CAB for PrEP
Our Biomedical Prevention Implementation Collaborative (BioPIC) teamed up with the HIV Modelling Consortium to produce this analysis of the potential impact of scaling up injectable cabotegravir (CAB) for PrEP, What can modelling tell us about the scale-up of CAB for PrEP? The findings can help implementers and policymakers understand what to expect and guide early policy decisions to maximize the impact of CAB for PrEP on the HIV epidemic.
Country Pages
PrEPWatch has added 35 new country pages where you can find the status of drug registration for PrEP products, data on PrEP initiations by product, country-level PEPFAR targets, and links to key policy documents and guidelines.
The Integrated Study Dashboard
Produced under the BioPIC project, the Integrated Study Dashboard tracks all currently known activities relating to implementation research, modelling, clinical research, and landscaping for new biomedical HIV PrEP options, including CAB for PrEP and the dapivirine vaginal ring (DVR), and has been recently expanded to include links to study results and study websites. The dashboard is updated in real time, and links to results will be added as they become available.
Tracking Country Planning for Product Introduction
The Country Planning for Product Introduction Matrix tracks key indicators for the introduction of injectable CAB and the DVR by country, including regulatory status, late-stage clinical trials and implementation research, procurement plans, and recent oral PrEP provision.
Training PrEP Champions
Among the most popular resources on PrEPWatch, the HIV Prevention Ambassador Training Package and Toolkit prepares potential and current PrEP users to be leaders – and “Ambassadors” – in the rollout of PrEP for HIV prevention in their communities. Developed as part of the MOSAIC project, it includes a training manual and resources for Ambassadors to use in peer outreach and community education.
Trends in PrEP Initiations
The Global PrEP Tracker provides quarterly updates on global trends in PrEP initiation by geography, delivery models, and more. The Global PrEP Tracker has become an indispensable resource for following the state of the field in delivering PrEP.
We hope these tools, created through strong partnerships and joint effort, support your work to accelerate the delivery of HIV prevention options. We are always interested in collaboration to ensure needed resources are developed and up to date. If you have information to share or resource needs, please let us know by reaching out to janki@avac.org and catherine@avac.org.
Avac Event
The inaugural edition of the African Workshop on HIV & Women will take place in hybrid format on 22 – 23 February 2024 in Nairobi, Kenya.
The time zone that will be used for this meeting is East Africa Time (EAT). If you need to convert the times to your timezone, this website might be of interest to you: www.WorldTimeBuddy.com.
This exciting new initiative is a regional workshop paired to the annual “International Workshop on HIV & Women”. It is an outstanding opportunity for both local and international healthcare providers, researchers, government, industry, and community representatives to discuss and further increase their knowledge on the issues related to HIV and women living in Africa.
The primary purpose of this workshop is to support changes that will provide a better quality of life for women living with HIV and reduce HIV transmissions in the region.
The format of the workshop enables attendees to learn from renowned HIV experts, discuss challenges, gaps, and opportunities for further learning and research. The debates and roundtables are an especially important vehicle to discuss issues and challenge dogma.
The workshop also provides a forum for early-career investigators to present their research and to personally meet with experts they view as mentors and inspiration for their work.
The meeting organizers hope this workshop will catalyze forming a community, where attendees continue to participate yearly and form valuable relationships and partnerships that lead to collaborative projects and positive changes.
Regular fee deadline, February 8.
Avac Event
During this webinar, the PrEPVacc team and AVAC reviewed the status of the PrEPVacc trial. PrEPVacc, a 3-in-1 trial testing two different vaccine candidates (plus placebo arm) and two daily oral PrEP regimens, recently discontinued vaccinations in the trial due to an independent data review board’s conclusion that the vaccines were having no effect in preventing HIV infection. On this call, we will review key aspects of PrEPVacc, including its innovative study design, implementation, integrated social science, and data analysis plans. Speakers engaged in conversation about what we’ve learned from PrEPVacc, what we can still learn, and what this may mean for the HIV prevention field.
Recording / Sheena McCormack Slides / Eugene Ruzagira Slides / Rachel Kawuma Slides / Sheila Kansiime Slides